Pictet Asset Management Holding SA Grows Stake in Teleflex Incorporated $TFX

Pictet Asset Management Holding SA lifted its position in Teleflex Incorporated (NYSE:TFX) by 2,289.0% during the 1st quarter, HoldingsChannel reports. The firm owned 165,842 shares of the medical technology company’s stock after buying an additional 158,900 shares during the period. Pictet Asset Management Holding SA’s holdings in Teleflex were worth $19,836,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in TFX. AQR Capital Management LLC boosted its stake in Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock valued at $287,603,000 after buying an additional 1,956,811 shares during the period. Abrams Bison Investments LLC bought a new position in Teleflex in the 3rd quarter worth about $112,317,000. Norges Bank purchased a new stake in shares of Teleflex in the 4th quarter valued at about $66,076,000. Wolf Hill Capital Management LP purchased a new stake in shares of Teleflex in the 4th quarter valued at about $47,405,000. Finally, Capital International Investors bought a new stake in shares of Teleflex during the 3rd quarter valued at about $44,851,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Up 2.5%

Shares of TFX opened at $129.89 on Thursday. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $139.67. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The stock has a 50 day simple moving average of $129.85 and a two-hundred day simple moving average of $119.63. The firm has a market cap of $5.75 billion, a P/E ratio of -5.70, a P/E/G ratio of 0.94 and a beta of 0.82.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.21 by $0.18. The firm had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business’s revenue was up 32.3% compared to the same quarter last year. During the same period last year, the firm posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is currently -5.96%.

Analyst Ratings Changes

Several research analysts have recently commented on TFX shares. Wall Street Zen raised Teleflex from a “sell” rating to a “hold” rating in a report on Saturday, June 27th. Mizuho set a $140.00 target price on shares of Teleflex in a research report on Friday, May 8th. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target for the company in a research note on Monday, April 13th. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Finally, Raymond James Financial restated an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Four equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Teleflex currently has a consensus rating of “Hold” and an average price target of $146.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.